Transcriptionally regulated by CCAAT enhancer binding protein (CEBP) beta (CEBPB), LOC102724169 shows low expression and correlates with poor progression-free survival (PFS) in OCCS patients. The gene discussed is CEBPB; the disease is oculocerebrocutaneous syndrome.